Who Paid My Doc
Moustafa Mourad
Facial Plastic Surgery New York, NY Medical Doctor
NPI 1710276753 CMS profile 1395344
923 5Th Ave Apt 1A, New York, NY 10021
General payments
$837
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Moustafa Mourad of New York, NY is reported in the CMS Open Payments database as having received $837 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 41st percentile of Facial Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $155 | 1 | |
| 2024 | General | $225 | 1 | |
| 2023 | General | $312 | 2 | |
| 2019 | General | $146 | 1 |
Beside peers
- Moustafa Mourad
- Facial Plastic Surgery median
- Middle half of Facial Plastic Surgery
- National median
In program year 2025, general payments to Moustafa Mourad were reported at $155. Among 437 Facial Plastic Surgery profiles paid that year, the median was $270 and the middle half received between $116 and $579.
Show as a table
| Year | Moustafa Mourad | Facial Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $146 | $225 | $92–$651 | $163 |
| 2020 | $0 | $132 | $45–$323 | $114 |
| 2021 | $0 | $186 | $67–$558 | $132 |
| 2022 | $0 | $218 | $83–$594 | $149 |
| 2023 | $312 | $237 | $94–$564 | $160 |
| 2024 | $225 | $233 | $104–$575 | $164 |
| 2025 | $155 | $270 | $116–$579 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 25 billing codesPaid by Medicare
$11,641
Medicare patients
30
Services billed
104
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 70% | |
| Arthritis | 53% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Facial Plastic Surgery in New York
Ran Rubinstein
Facial Plastic Surgery · Newburgh, NY
Joshua Rosenberg
Facial Plastic Surgery · New York, NY
Allison Pontius
Facial Plastic Surgery · New York, NY
Michael Cohen
Facial Plastic Surgery · Syosset, NY
Daniel Lee
Facial Plastic Surgery · Latham, NY
Lesley Rabach
Facial Plastic Surgery · New York, NY
Related records
Facial Plastic Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Facial Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.